Business
Aurora Launches Daily Special(TM) in Germany, Delivering High-Quality, Affordable Medical Cannabis to Patients
Aurora Launches Daily Special™ in Germany, Delivering High-Quality, Affordable Medical Can...
About this update from Aurora Cannabis Inc.
[{"type":"text","content":"\n\n\nAurora Launches Daily Special™ in Germany, Delivering High-Quality, Affordable Medical Cannabis to Patients\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntar{\nTEXT-ALIGN: RIGHT\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n\n\n\n\n\nCanada NewsWire\n\n\nNASDAQ | TSX: ACB\nDaily Special™ launch expands Aurora's leading portfolio of medical cannabis products available in the company's fastest growing market  \nEDMONTON, AB, Dec. 18, 2025 /CNW/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces the launch of Daily Special™,  a new medical cannabis brand for the German market. Designed to offer reliable, high-quality flower at an accessible price point, the Daily Special brand is an exciting addition to Germany's rapidly growing medical cannabis sector, following record performance for the company.\n\n\n\n\n\n\n\nWith this launch, Aurora strengthens its commitment to expanding patient choice, improving affordability, and delivering consistent, pharmaceutical-grade products backed by global GMP production standards.\n\"The launch of Daily Special in Germany is a clear demonstration of Aurora's long-term investment and leadership in one of the world's most important medical cannabis markets and key region for the company,\" said, Andreas Dotterweich, Senior Vice President, Aurora Europe. \"As a global leader, we are uniquely positioned to introduce a new brand that we believe will resonate with patients and support the development of Germany's medical cannabis sector as it enters its next phase of growth.\"\nAvailable at German pharmacies and through Telemedicine platforms from December 19, 2025, the Daily Special launch introduces a sativa-dominant cultivar born from Gelonade × Biscotti, with a range of 21-23% THC < 1% CBD. Delivering a vibrant sensory experience highlighted by intense citrus, sweet-earthy, and diesel-forward aromas and a rich terpene profile contributes to its distinctive character and premium appeal.\nWith one of the world's largest cannabis genetic ...